GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Acura Pharmaceuticals ACUR · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Acura Pharmaceuticals — daily ACUR Delayed
Market value
$17,040
Last close × shares
Volume
400
Shares, 4 Nov 2026

About Acura Pharmaceuticals

Its shares trade under the ticker ACUR. It has been listed since 12 September 2000. In the fiscal year to 31 December 2021, it reported revenue of $1.6m and a net loss of $879,000. At that date it held total assets of $860,000 and shareholders' equity of $178,000.

Acura Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. The company is headquartered in Palatine, Illinois. The company went IPO on 2000-09-12. The firm is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The firm has discovered and developed three platform technologies, which can be used to develop multiple products. The firm's Oxaydo Tablets (oxycodone HCl, CII), which utilizes the Aversion Technology, is an approved and immediate-release (IR) oxycodone product in the United States. The firm's Impede technology products include Nexafed and Nexafed Sinus Pressure + Pain. Its third deterrent technology is Limitx, which is designed to retard the release of active drug ingredients when too many tablets are accidently or purposefully ingested. The firm's Aversion and Limitx technologies are intended to address methods associated with opioid and its Impede technology is directed at the extraction and conversion of pseudoephedrine into methamphetamine.

Figures and description from our data supplier, not checked against the company's own report.

More about Acura Pharmaceuticals →

Latest on Acura Pharmaceuticals

Our reporting

We have not reported on Acura Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Acura Pharmaceuticals's ticker?

Acura Pharmaceuticals trades as ACUR on its US listing, under ISIN US00509L8028.

What was Acura Pharmaceuticals's last closing price?

0.00 on 4 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.